These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 23722418)

  • 1. Beneficial effects of intracoronary nicorandil on microvascular dysfunction after primary percutaneous coronary intervention: demonstration of its superiority to nitroglycerin in a cross-over study.
    Ito N; Nanto S; Doi Y; Kurozumi Y; Natsukawa T; Shibata H; Morita M; Kawata A; Tsuruoka A; Sawano H; Okada K; Sakata Y; Kai T; Hayashi T
    Cardiovasc Drugs Ther; 2013 Aug; 27(4):279-87. PubMed ID: 23722418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High index of microcirculatory resistance level after successful primary percutaneous coronary intervention can be improved by intracoronary administration of nicorandil.
    Ito N; Nanto S; Doi Y; Sawano H; Masuda D; Yamashita S; Okada K; Kaibe S; Hayashi Y; Kai T; Hayashi T
    Circ J; 2010 May; 74(5):909-15. PubMed ID: 20234097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicorandil prevents microvascular dysfunction resulting from PCI in patients with stable angina pectoris: a randomised study.
    Hirohata A; Yamamoto K; Hirose E; Kobayashi Y; Takafuji H; Sano F; Matsumoto K; Ohara M; Yoshioka R; Takinami H; Ohe T
    EuroIntervention; 2014 Jan; 9(9):1050-6. PubMed ID: 24457276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect on myocardial perfusion and clinical outcome of intracoronary nicorandil injection prior to percutaneous coronary intervention in ST-segment elevation myocardial infarction].
    Wang ZQ; Chen MX; Liu DL; Zheng WX; Cao XZ; Chen H; Huang MF; Luo ZR
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jan; 45(1):26-33. PubMed ID: 28100342
    [No Abstract]   [Full Text] [Related]  

  • 5. Myocardial protective effect of intracoronary administration of nicorandil and alprostadil via targeted perfusion microcatheter in patients undergoing elective percutaneous coronary intervention: A randomized controlled trial.
    Zhang W; Dai J; Zheng X; Xu K; Yang X; Shen L; Wang X; Hao Z; Qiu X; Jiang L; Shi H; Shen L; He B
    Medicine (Baltimore); 2021 Apr; 100(15):e25551. PubMed ID: 33847683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of nicorandil on microvascular function in patients with ST segment elevation myocardial infarction undergoing primary PCI.
    Kostic J; Djordjevic-Dikic A; Dobric M; Milasinovic D; Nedeljkovic M; Stojkovic S; Stepanovic J; Tesic M; Trifunovic Z; Zamaklar-Tifunovic D; Radosavljevic-Radovanovic M; Ostojic M; Beleslin B
    Cardiovasc Ultrasound; 2015 May; 13():26. PubMed ID: 26012474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of intracoronary administration of anisodamine on slow reflow phenomenon following primary percutaneous coronary intervention in patients with acute myocardial infarction.
    Fu XH; Fan WZ; Gu XS; Wei YY; Jiang YF; Wu WL; Li SQ; Hao GZ; Wei QM; Xue L
    Chin Med J (Engl); 2007 Jul; 120(14):1226-31. PubMed ID: 17697572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive value of the index of microcirculatory resistance in patients with ST-segment elevation myocardial infarction.
    Fearon WF; Shah M; Ng M; Brinton T; Wilson A; Tremmel JA; Schnittger I; Lee DP; Vagelos RH; Fitzgerald PJ; Yock PG; Yeung AC
    J Am Coll Cardiol; 2008 Feb; 51(5):560-5. PubMed ID: 18237685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of a single intravenous administration of nicorandil before reperfusion in patients with ST-segment-elevation myocardial infarction.
    Ishii H; Ichimiya S; Kanashiro M; Amano T; Imai K; Murohara T; Matsubara T
    Circulation; 2005 Aug; 112(9):1284-8. PubMed ID: 16116055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Early Intracoronary Administration of Nicorandil During Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction.
    Feng C; Liu Y; Wang L; Niu D; Han B
    Heart Lung Circ; 2019 Jun; 28(6):858-865. PubMed ID: 29891250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracoronary EnalaPrilat to Reduce MICROvascular Damage During Percutaneous Coronary Intervention (ProMicro) study.
    Mangiacapra F; Peace AJ; Di Serafino L; Pyxaras SA; Bartunek J; Wyffels E; Heyndrickx GR; Wijns W; De Bruyne B; Barbato E
    J Am Coll Cardiol; 2013 Feb; 61(6):615-21. PubMed ID: 23290547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rationale and design of a large-scale trial using nicorandil as an adjunct to percutaneous coronary intervention for ST-segment elevation acute myocardial infarction: Japan-Working groups of acute myocardial infarction for the reduction of Necrotic Damage by a K-ATP channel opener (J-WIND-KATP).
    Minamino T; Jiyoong K; Asakura M; Shintani Y; Asanuma H; Kitakaze M;
    Circ J; 2004 Feb; 68(2):101-6. PubMed ID: 14745142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracoronary ECG during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction predicts microvascular obstruction and infarct size.
    Wong DT; Leung MC; Das R; Liew GY; Teo KS; Chew DP; Meredith IT; Worthley MI; Worthley SG
    Int J Cardiol; 2013 Apr; 165(1):61-6. PubMed ID: 21875755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Index of Microcirculatory Resistance Postpercutaneous Coronary Intervention Predicts Left Ventricular Recovery in Patients With Thrombolyzed ST-Segment Elevation Myocardial Infarction.
    Palmer S; Layland J; Carrick D; Williams PD; Judkins C; Gong FF; Burns AT; Whitbourn RJ; MacIsaac AI; Wilson AM
    J Interv Cardiol; 2016 Apr; 29(2):146-54. PubMed ID: 26822384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect on periprocedural myocardial infarction of intra-coronary nicorandil prior to percutaneous coronary intervention in stable and unstable angina.
    Hwang J; Lee HC; Kim BW; Yang MJ; Park JS; Park JH; Lee HW; Oh J; Choi JH; Cha KS; Hong TJ; Song S; Kim SP
    J Cardiol; 2013 Aug; 62(2):77-81. PubMed ID: 23731922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Open-label, randomized, placebo-controlled evaluation of intracoronary adenosine or nitroprusside after thrombus aspiration during primary percutaneous coronary intervention for the prevention of microvascular obstruction in acute myocardial infarction: the REOPEN-AMI study (Intracoronary Nitroprusside Versus Adenosine in Acute Myocardial Infarction).
    Niccoli G; Rigattieri S; De Vita MR; Valgimigli M; Corvo P; Fabbiocchi F; Romagnoli E; De Caterina AR; La Torre G; Lo Schiavo P; Tarantino F; Ferrari R; Tomai F; Olivares P; Cosentino N; D'Amario D; Leone AM; Porto I; Burzotta F; Trani C; Crea F
    JACC Cardiovasc Interv; 2013 Jun; 6(6):580-9. PubMed ID: 23683738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute effect of sodium nitroprusside on microvascular dysfunction in patients who underwent percutaneous coronary intervention for acute ST-segment elevation myocardial infarction.
    Morimoto K; Ito S; Nakasuka K; Sekimoto S; Miyata K; Inomata M; Yoshida T; Tamai N; Saeki T; Suzuki S; Murakami Y; Sato K; Morino A; Shimizu Y
    Int Heart J; 2012; 53(6):337-40. PubMed ID: 23258132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Hematologic Parameters on Microvascular Reperfusion in Patients With ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention.
    Karahan Z; Uçaman B; Uluğ AV; Aydınalp Ö; Uğurlu M; Çevik K; Kaya İ; Öztürk Ö
    Angiology; 2016 Feb; 67(2):151-6. PubMed ID: 26007233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impacts of nicorandil on infarct myocardium in comparison with nitrate: assessed by cardiac magnetic resonance imaging.
    Yamada K; Isobe S; Ishii H; Yokouchi K; Iwata H; Sawada K; Murohara T
    Heart Vessels; 2016 Sep; 31(9):1430-7. PubMed ID: 26531829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of high-dose atorvastatin loading before primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: the STATIN STEMI trial.
    Kim JS; Kim J; Choi D; Lee CJ; Lee SH; Ko YG; Hong MK; Kim BK; Oh SJ; Jeon DW; Yang JY; Cho JR; Lee NH; Cho YH; Cho DK; Jang Y
    JACC Cardiovasc Interv; 2010 Mar; 3(3):332-9. PubMed ID: 20298994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.